Shares Outstanding for Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's latest reported diluted shares outstanding is 2.45B. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingShares OutstandingSwitch metric
Latest period
2.45B
YoY change
0.0%
5Y CAGR
-1.9%
Peak year (2003)
3.14B
Latest annual
2.43B
Shares Outstanding history chart for Johnson & Johnson (JNJ) from 1985 to 2025
Shares Outstanding history table for Johnson & Johnson (JNJ) from 1985 to 2025
| Fiscal year | Period ended | Reported | Shares Outstanding | YoY |
|---|---|---|---|---|
| 2025 | 2.43B | 0.0% | ||
| 2024 | 2.43B | -5.1% | ||
| 2023 | 2.56B | -3.9% | ||
| 2022 | 2.66B | -0.4% | ||
| 2021 | 2.67B | +0.1% | ||
| 2020 | 2.67B | -0.5% | ||
| 2019 | 2.68B | -1.6% | ||
| 2018 | 2.73B | -0.6% | ||
| 2017 | 2.75B | -1.6% | ||
| 2016 | 2.79B | -0.9% | ||
| 2015 | 2.81B | -1.8% | ||
| 2014 | 2.86B | -0.5% | ||
| 2013 | 2.88B | +2.3% | ||
| 2012 | 2.81B | +1.3% | ||
| 2011 | 2.78B | -0.5% | ||
| 2010 | 2.79B | -0.0% | ||
| 2009 | 2.79B | -1.6% | ||
| 2008 | 2.84B | -2.6% | ||
| 2007 | 2.91B | -1.8% | ||
| 2006 | 2.96B | -1.3% | ||
| 2005 | 3.00B | +0.6% | ||
| 2004 | 2.99B | -5.0% | ||
| 2003 | 3.14B | +2.9% | ||
| 2002 | 3.05B | -0.9% | ||
| 2001 | 3.08B | -0.6% | ||
| 2000 | 3.10B | +0.8% | ||
| 1999 | 3.07B | +8.5% | ||
| 1998 | 2.83B | +3.4% | ||
| 1997 | 2.74B | +0.5% | ||
| 1996 | 2.73B | +5.5% | ||
| 1995 | 2.58B | -0.8% | ||
| 1994 | 2.61B | -0.8% | ||
| 1993 | 2.63B | +0.0% | ||
| 1992 | 2.63B | -2.9% | ||
| 1991 | 2.71B | +0.6% | ||
| 1990 | 2.69B | -0.6% | ||
| 1989 | 2.71B | -2.8% | ||
| 1988 | 2.78B | +1.9% | ||
| 1987 | 2.73B | -0.5% | ||
| 1986 | 2.75B | -6.0% | ||
| 1985 | 2.92B | — |
Shares Outstanding values are taken from Johnson & Johnson's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual diluted shares outstanding for Johnson & Johnson (JNJ) came in at 2.43B – edged up 0.0% year-over-year.
Johnson & Johnson diluted shares outstanding compound annual growth for the 2020–2025 (5 years) window is -1.9%, with a net decline across the window.
Between 2003 and 2025, Johnson & Johnson diluted shares outstanding declined 22.7%, falling from 3.14B to 2.43B.
2003 marks the peak diluted shares outstanding at 3.14B, with the historical low of 2.43B recorded in 2024.
Johnson & Johnson (JNJ) sits 3rd of 8 Healthcare peers we track on this metric, against a peer median of 904.00M.
Johnson & Johnson Shares Outstanding by Year
Johnson & Johnson Shares Outstanding 2025: 2.43B
Johnson & Johnson diluted shares outstanding in 2025 was 2.43B, edged up 0.0% from 2024.
Johnson & Johnson Shares Outstanding 2024: 2.43B
Johnson & Johnson diluted shares outstanding in 2024 was 2.43B, declined 5.1% below 2023. This figure represents the lowest annual value in the available history.
Johnson & Johnson Shares Outstanding 2023: 2.56B
Johnson & Johnson diluted shares outstanding in 2023 was 2.56B, edged down 3.9% below 2022.
Johnson & Johnson Shares Outstanding 2022: 2.66B
Johnson & Johnson diluted shares outstanding in 2022 was 2.66B, edged down 0.4% below 2021.
Johnson & Johnson Shares Outstanding 2021: 2.67B
Johnson & Johnson diluted shares outstanding in 2021 was 2.67B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers — Shares Outstanding
Companies in the same sector as Johnson & Johnson, ranked by their latest diluted shares outstanding.
| Company | Shares Outstanding | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | 4.45B | Healthcare |
| Merck & Co., Inc. (MRK) | 2.51B | Healthcare |
| AbbVie Inc. (ABBV) | 1.77B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | 910.00M | Healthcare |
| Eli Lilly and Company (LLY) | 898.00M | Healthcare |
| AstraZeneca PLC (AZN) | 781.00M | Healthcare |
| Amgen Inc. (AMGN) | 542.00M | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | 377.00M | Healthcare |
Frequently asked questions
What is Johnson & Johnson's diluted shares outstanding?
- Latest reported diluted shares outstanding for Johnson & Johnson (JNJ) is 2.45B (period ending March 31, 2026).
How has Johnson & Johnson diluted shares outstanding changed year-over-year?
- Johnson & Johnson (JNJ) diluted shares outstanding changed 0.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Johnson & Johnson diluted shares outstanding?
- Johnson & Johnson (JNJ) diluted shares outstanding compound annual growth rate is -1.9% over the most recent 5 years available.
When did Johnson & Johnson diluted shares outstanding hit its highest annual value?
- Johnson & Johnson diluted shares outstanding reached its highest annual value of 3.14B in 2003.
What was Johnson & Johnson diluted shares outstanding in 2024?
- Johnson & Johnson (JNJ) diluted shares outstanding in 2024 was 2.43B.
What was Johnson & Johnson diluted shares outstanding in 2025?
- Johnson & Johnson (JNJ) diluted shares outstanding in 2025 was 2.43B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
JNJ Overview
Company profile, financial tools, and key metrics
JNJ Revenue Counter
Earns $3,066 every second. See per minute, hour, and day.
JNJ Earnings Counter
Earns $657.60 per second net profit. See per minute, hour, and day.
JNJ Economic Scale
Exceeds Costa Rica's GDP. Compare with world economies.
JNJ What If Invested
What if you had invested $1,000? See historical returns from any date.
JNJ How It Makes Money
Discover visual breakdown of $96.68B in revenue — where it comes from and where it goes.
JNJ Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
JNJ Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
JNJ Daily Price Character
Steady · 47.0% historical win rate (green days). Streaks & record days.
JNJ Buybacks
1.00% TTM buyback yield. Shareholder yield & SBC comparison.
JNJ Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
JNJ Dividend Profile
Yield: 2.29%. Safety: 6/8. See full history.
JNJ Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
JNJ Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.